Condition: Schizophrenia · Sponsor: Central South University
Schizophrenia is a severe mental illness associated with significant morbidity and disability. Patients often experience metabolic side effects from antipsychotic medications, including weight gain and dyslipidemia. Statins, commonly used to manage dyslipidemia, can lower cholesterol levels but may increase the risk of new-onset diabetes. This study aims to investigate how atorvastatin affects glucose metabolism in schizophrenia patients and assess whether metformin can help improve these metabolic issues. The investigators will include 200 patients with dyslipidemia from the Second Xiangya Hospital and other sites, randomly assigning them to receive either atorvastatin with metformin or atorvastatin with placebo over six months. Key goals include evaluating the impact of atorvastatin on insulin resistance and blood glucose levels and determining the effectiveness of metformin in mitigating glucose metabolism abnormalities while managing lipid levels. Understanding these interactions will help improve treatment strategies for schizophrenia patients, potentially lowering their risk of cardiovascular diseases and diabetes and enhancing overall health outcomes.
This description comes directly from the study's public registry record.
Jing Huang · +86 15874290980 · jinghuangserena@csu.edu.cn
Xinyi Zhao · +86 17803908545 · 852646662@qq.com
Always discuss trial participation with your own doctor first.
| Zhumadian Second People's Hospital | Zhumadian, Henan, China | Active Not Recruiting |
| Mental Health Institute of Second Xiangya Hospital, CSU | Changsha, Hunan, China | Recruiting |
| The Third Hospital of Changsha County | Changsha, Hunan, China | Recruiting |
| The Second People's Hospital of Xiangyin County | Yueyang, Hunan, China | Recruiting |
| Junshan District Psychiatric Rehabilitation Hospital | Yueyang, Hunan, China | Recruiting |
| Yueyang Rehabilitation Hospital | Yueyang, Hunan, China | Recruiting |
| The Second People's Hospital of Dali Bai Autonomous Prefecture | Dali, Yunnan, China | Active Not Recruiting |
| Xiangshan County Traditional Chinese Medicine Hospital Medical and Health Group Three Hospitals District | Xiangshan, Zhejiang, China | Active Not Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07045142